GCA
IBB icon

Genesee Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Genesee Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-430
Closed -$48K – 84
2019
Q1 		$48K Hold
430
– – 0.06% 73
2018
Q4 		$42K Buy
+430
New +$45.6K 0.07% 51

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Genesee Capital Advisors's IBB Position: Q2 2019 in Review

Genesee Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 430 shares — an estimated $48K sold.

Genesee Capital Advisors first reported a position in IBB in Q4 2018 and held it in 2 quarters. The position peaked at $48K in Q1 2019. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

  • Genesee Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
  • Genesee Capital Advisors sold 430 iShares Biotechnology ETF shares in Q2 2019, an estimated $48K.
  • Genesee Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 2 quarters.
  • Genesee Capital Advisors's iShares Biotechnology ETF position peaked at $48K in Q1 2019.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Genesee Capital Advisors's 13F filing for Q2 2019, filed 19 Jul 2019.